Clinical Trials Browser

Phase 2 × Uveal Melanoma × Thalidomide × Clear all

NCT00238329 2013-04-08

PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma

Phase 2 Completed

Uveal Melanoma, Melanoma

NCT00072345 2013-01-18

Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma

Phase 2 Completed

Uveal Melanoma, Melanoma